Husqvarna AB ser. B (0GTR)
London Exchange · UK · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 33.11 |
|---|---|
| 52-week range | 31.21 – 48.69 |
| Return, 1 month / 3 months | −5.0% / −10.6% |
| Return, 1 year / 3 years | −27.7% / −48.6% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 21.61M SEK |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Husqvarna AB is a Swedish manufacturer of outdoor power products and equipment for forestry, landscaping and construction work. Its range includes chainsaws, trimmers, lawn mowers and robotic mowers for homeowners and professional gardeners, along with cutting and drilling equipment used on building sites. The company also makes watering products and garden tools. It is based in Sweden and sells its products to consumers, contractors and trade customers in markets around the world.
The shares are listed on the London Exchange in UK under the code 0GTR, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Husqvarna AB ser. B (0GTR) trades on the London Exchange in UK. It last closed at SEK 33.11 on 23 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 2,707 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 27.7% and over the last three months it fell 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.3% | ||
| From 52-week high | -31.2% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.6% | ||
| 6-month return | -27.3% | ||
| 12-month return, skipping the last month | -23.8% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 21.61M SEK | ||
| Zero-volume days | 8.3% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.8% |
|---|---|
| 1 month | −5.0% |
| 3 months | −10.6% |
| 6 months | −27.3% |
| 1 year | −27.7% |
| 3 years | −48.6% |
| 5 years | −66.0% |
Signals
| 50-day / 200-day average | 35.90 / 39.54 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | SEK 0.5000 |
| 30 Oct 2025 | SEK 0.5000 |
| 30 Apr 2025 | SEK 0.5000 |
| 21 Oct 2024 | SEK 2.0000 |
| 19 Apr 2024 | SEK 1.0000 |
| 5 Oct 2023 | SEK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.